Literature DB >> 12691799

Quadrigeminal non-aneurysmal subarachnoid hemorrhage--a true variant of perimesencephalic subarachnoid hemorrhage. Case report.

Theodore H Schwartz1, Jeffrey Farkas.   

Abstract

Spontaneous non-aneurysmal subarachnoid hemorrhage (SAH) centered in the quadrigeminal cistern has been proposed as a variant of perimesencephalic non-aneurysmal SAH (PNSH). Some authors contest the existence of this entity, claiming it results either from head trauma or an undiscovered P2-P3 aneurysm, and conclude that all PNSH arise in front of the brainstem in a 'pretruncal' location. We report a patient with a quadrigeminal pattern of subarachnoid blood who was investigated with two digital catheter angiograms, including 3-D angiography, plus a high-resolution computed tomography angiogram. No abnormal findings were present and the patient had an excellent outcome. We propose that the more common pretruncal PNSH and less common quadrigeminal PNSH are two types of perimesencephalic SAH with separate, distinct etiologies, both of which have a more benign clinical course than aneurysmal SAH.

Entities:  

Mesh:

Year:  2003        PMID: 12691799     DOI: 10.1016/s0303-8467(02)00112-9

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Cerebral aneurysm exclusion by CT angiography based on subarachnoid hemorrhage pattern: a retrospective study.

Authors:  Marc Kelliny; Philippe Maeder; Stefano Binaghi; Marc Levivier; Luca Regli; Reto Meuli
Journal:  BMC Neurol       Date:  2011-01-21       Impact factor: 2.474

2.  The CT pattern of a ruptured P3 posterior cerebral artery aneurysm.

Authors:  Vivien H Lee; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

3.  Glioblastoma mimicking an arteriovenous malformation.

Authors:  Arjun Khanna; Andrew S Venteicher; Brian P Walcott; Kristopher T Kahle; Daniel A Mordes; Christopher M William; Zoher Ghogawala; Christopher S Ogilvy
Journal:  Front Neurol       Date:  2013-09-30       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.